Evidence map›Paper›PMID 36176918›Full record

ArticleTranslational biophotonics2022

Fiber-based hand-held RCM-OCT probe for noninvasive assessment of skin lesions and therapy guidance.

Gopi Maguluri, John Grimble, Mircea Mujat, Jesung Park, Aliana Caron, Nicusor Iftimia

Open access · goldAbstract read
In one paragraph

Article in Translational biophotonics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Gopi MaguluriPhysical Sciences, Inc., Andover, MA, USA.
John GrimblePhysical Sciences, Inc., Andover, MA, USA.
Mircea MujatPhysical Sciences, Inc., Andover, MA, USA.
Jesung ParkPhysical Sciences, Inc., Andover, MA, USA.
Aliana CaronPhysical Sciences, Inc., Andover, MA, USA.
Nicusor IftimiaPhysical Sciences, Inc., Andover, MA, USA.
Physical Sciences (United States) · US

Funding

Multimodal Optical Probe for Skin Cancer Detection and Therapy GuidanceR44CA240040 · NCI · PHYSICAL SCIENCES, INC · PI IFTIMIA, NICUSOR · 2019 to 2021
$1.7M
NCI NIH HHS R44 CA240040
6 · The paper itself

Abstract

Noninvasive assessment of skin lesions, especially of basal cell carcinoma (BCC), has benefited more recently from the use of optical imaging techniques such as optical coherence tomography (OCT) and reflectance confocal microscopy (RCM). While RCM provides submicron scale resolution and thus enables identification of skin morphological changes of the skin, with the downside of limited penetration depth, OCT imaging of the same lesion brings the benefit of better resolving its depth of invasion. OCT and RCM can be used either individually or combined within the same instrument for the noninvasive diagnosis of nonmelanoma skin cancers (NMSCs). Their combined use has shown to provide certain benefits such as better characterization of the lesion's margins, both in depth and laterally, as well as improved sensitivity and specificity, as previously demonstrated by our team. In this paper we report a new "fiber-based" implementation of the second-generation RCM-OCT hand-held probe. The fiber-based implementation of both imaging modalities enabled the construction of a smaller footprint/lower weight hand-held probe. Its preliminary evaluation on the skin of healthy volunteers is reported here, demonstrating improved capabilities for resolving sub-cellular structures and image skin morphology with micron-scale resolution to a higher depth than in the previous implementation, while also enabling the construction of angiography maps showing vascular remodeling.

Indexed as

noninvasive evaluationoptical coherence tomographyreflectance confocal microscopyskin lesions

Identifiers

PMID36176918
PMCPMC9514145
OpenAlexW4281841214

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.